chemoradiation
Showing 1 - 20 of 20
Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva Trial (Paclitaxel and Carboplatin, Chemoradiation)
Not yet recruiting
- Locally Advanced Vulvar Carcinoma
- Squamous Cell Carcinoma of the Vulva
- Paclitaxel and Carboplatin
- Chemoradiation
- (no location specified)
Jun 6, 2023
Uterine Cervical Tumors Trial in Brazil (Nivolumab 40 mg in 4 ml Injection, Ipilimumab 200 MG in 40 ML Injection,
Not yet recruiting
- Uterine Cervical Neoplasms
- Nivolumab 40 mg in 4 ml Injection
- +2 more
-
Salvador, Bahia, Brazil
- +13 more
Aug 5, 2022
Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)
Active, not recruiting
- Esophageal Carcinoma
- mFOLFOX6
- Chemoradiation
-
Rochester, New YorkUniversity of Rochester
Aug 17, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
Pancreatic Cancer Trial in Milwaukee (First-line Chemotherapy, Second-line Chemotherapy, Chemoradiation)
Recruiting
- Pancreatic Cancer
- First-line Chemotherapy
- +2 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jul 29, 2022
Rectal Adenocarcinoma Trial in Chapel Hill (other, radiation, drug)
Withdrawn
- Rectal Adenocarcinoma
- Chemoradiation
- +4 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Nov 2, 2021
Oropharynx Cancer Trial in France (Nivolumab, Chemoradiation)
Active, not recruiting
- Oropharynx Cancer
- Nivolumab
- Chemoradiation
-
Avignon, France
- +10 more
Apr 11, 2022
Pancreatic Adenocarcinoma Trial in Philadelphia (Gemcitabine, Abraxane, FOLFIRINOX)
Completed
- Pancreatic Adenocarcinoma
- Gemcitabine
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 24, 2021
Esophagus Cancer, Chemoradiotherapy, Oligometastatic Disease Trial in Beijing (PD-1 antibody, Chemoradiation, Albumin-Bound
Recruiting
- Esophagus Cancer
- +3 more
- PD-1 antibody
- +3 more
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/Nationa
Mar 26, 2021
Rectal Cancer, Chemo Effect Trial (Chemoradiation, FOLFOXIRI Protocol, Folfox Protocol)
Not yet recruiting
- Rectal Cancer
- Chemotherapy Effect
- Chemoradiation
- +2 more
- (no location specified)
Jun 2, 2019
Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Avelumab, Chemoradiation)
Terminated
- Squamous Cell Carcinoma of the Head and Neck
- Avelumab
- Chemoradiation
-
Fayetteville, Arkansas
- +315 more
Sep 20, 2021
Pancreatic Tumors Trial in Worldwide (nab-Paclitaxel, Gemcitabine, Chemoradiation)
Cervical Cancer, Adjuvant Chemo, Radiation Trial in China (chemoradiation, Paclitaxel, Cisplatin)
Recruiting
- Cervical Cancer
- +3 more
- chemoradiation
- Paclitaxel, Cisplatin
-
Foshan, Guangdong, China
- +7 more
Mar 22, 2018
Adenocarcinoma of Head of Pancreas Trial in Charleston (drug, radiation, procedure)
Terminated
- Adenocarcinoma of Head of Pancreas
- Neo-adjuvant Chemotherapy
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Dec 11, 2015
Cancer of Cervix Trial in Recife (gemcitabine, cisplatin, chemoradiation)
Completed
- Cancer of Cervix
- gemcitabine
- +2 more
-
Recife, Pernambuco, BrazilInstituto de Medicina Integral Fernando Figueira
Oct 14, 2015
Tumors, Head and Neck Trial in Worldwide (drug, radiation, other)
Rectal Cancer Trial in Mumbai (Chemoradiation, Additional Radiation boost to the primary tumor volume)
Unknown status
- Rectal Cancer
- Chemoradiation
- Additional Radiation boost to the primary tumor volume
-
Mumbai, Maharashtra, IndiaTata Memorial Centre
Dec 12, 2008